U.S. flag

An official website of the United States government

NM_000196.4(HSD11B2):c.440G>A (p.Arg147His) AND not specified

Germline classification:
Uncertain significance (2 submissions)
Last evaluated:
May 25, 2023
Review status:
2 stars out of maximum of 4 stars
criteria provided, multiple submitters, no conflicts
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000518271.3

Allele description [Variation Report for NM_000196.4(HSD11B2):c.440G>A (p.Arg147His)]

NM_000196.4(HSD11B2):c.440G>A (p.Arg147His)

Gene:
HSD11B2:hydroxysteroid 11-beta dehydrogenase 2 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
16q22.1
Genomic location:
Preferred name:
NM_000196.4(HSD11B2):c.440G>A (p.Arg147His)
HGVS:
  • NC_000016.10:g.67435802G>A
  • NG_016549.1:g.9670G>A
  • NM_000196.4:c.440G>AMANE SELECT
  • NP_000187.3:p.Arg147His
  • NC_000016.9:g.67469705G>A
  • NM_000196.3:c.440G>A
  • p.ARG147HIS
Protein change:
R147H
Links:
dbSNP: rs13306425
NCBI 1000 Genomes Browser:
rs13306425
Molecular consequence:
  • NM_000196.4:c.440G>A - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Synonyms:
AllHighlyPenetrant
Identifiers:
MedGen: CN169374

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000613669Athena Diagnostics
criteria provided, single submitter

(Athena Diagnostics Criteria)
Uncertain significance
(Sep 26, 2016)
germlineclinical testing

PubMed (3)
[See all records that cite these PMIDs]

SCV003934346Women's Health and Genetics/Laboratory Corporation of America, LabCorp
criteria provided, single submitter

(LabCorp Variant Classification Summary - May 2015)
Uncertain significance
(May 25, 2023)
germlineclinical testing

PubMed (1)
[See all records that cite this PMID]

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

In silico structure-function analysis of pathological variation in the HSD11B2 gene sequence.

Manning JR, Bailey MA, Soares DC, Dunbar DR, Mullins JJ.

Physiol Genomics. 2010 Aug;42(3):319-30. doi: 10.1152/physiolgenomics.00053.2010. Epub 2010 Jun 22.

PubMed [citation]
PMID:
20571110
PMCID:
PMC2929884

A Standardized DNA Variant Scoring System for Pathogenicity Assessments in Mendelian Disorders.

Karbassi I, Maston GA, Love A, DiVincenzo C, Braastad CD, Elzinga CD, Bright AR, Previte D, Zhang K, Rowland CM, McCarthy M, Lapierre JL, Dubois F, Medeiros KA, Batish SD, Jones J, Liaquat K, Hoffman CA, Jaremko M, Wang Z, Sun W, Buller-Burckle A, et al.

Hum Mutat. 2016 Jan;37(1):127-34. doi: 10.1002/humu.22918. Epub 2015 Oct 29.

PubMed [citation]
PMID:
26467025
PMCID:
PMC4737317
See all PubMed Citations (3)

Details of each submission

From Athena Diagnostics, SCV000613669.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (3)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

From Women's Health and Genetics/Laboratory Corporation of America, LabCorp, SCV003934346.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)

Description

Variant summary: HSD11B2 c.440G>A (p.Arg147His) results in a non-conservative amino acid change in the encoded protein sequence. Four of five in-silico tools predict a benign effect of the variant on protein function. The variant allele was found at a frequency of 0.0002 in 250992 control chromosomes (gnomAD). This frequency is not significantly higher than estimated for a pathogenic variant in HSD11B2 causing Apparent Mineralocorticoid Excess (0.0002 vs 0.0035), allowing no conclusion about variant significance. c.440G>A has been reported in the literature in individuals affected with hypertension without strong evidence of causality and at a similar frequency as the general population (Kamide_2006). This report does not provide unequivocal conclusions about association of the variant with Apparent Mineralocorticoid Excess. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. The following publication has been ascertained in the context of this evaluation (PMID: 16778331). Two clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014, and classified the variant as uncertain significance. Based on the evidence outlined above, the variant was classified as uncertain significance.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: May 7, 2024